Welcome to LiVDerm
Where the Constellations of Medical Dermatology and Aesthetics Collide
Led by world-renowned experts in the field, LiVDerm is a comprehensive dermatologic hub where medical professionals educate, collaborate, and engage.
LiVDerm’s mission is to boldly advance higher standards of dermatology care through live and virtual educational offerings, resources for providers, students and patients, and much more.
As a leading source for the latest therapies, technologies, procedures, and practice guidelines in medical and aesthetic dermatology, LiVDerm empowers providers to manage dermatologic conditions with confident authority. With a multipronged focus on the myriad specialties within the field, LiVDerm provides innovative and integrated education across the dermatology spectrum.
Upcoming Live Events
- February 8- 9 , 2024
- Miami Beach, FL
Complimentary Continuing Education
Hidradenitis Suppurativa
Virtual Symposium
Timely Management of HS: Addressing Barriers to Care for Patients in Need
Alopecia Areata
Virtual Symposium
Gamechangers in Alopecia Areata: Targeted Therapies for Patient-Centered Care
Psoriasis
Virtual Symposium
A New Age in Pediatric Psoriasis: Case-Based Learning for Inclusive Care
Atopic Dermatitis
Virtual Symposium
Infants and Atopic Dermatitis: The Biggest Help for the Smallest Patients
Rare Diseases
Clinical Brief
Updates in Managing Rare Diseases: Tips for the Practicing Dermatologist
Alopecia Areata
Webcast
PRIMER: Gamechangers in Alopecia Areata: Targeted Therapies for Patient-Centered Care
Atopic Dermatitis
Clinical Brief
The New Kids on the Block: IL-13 Inhibitors for the Treatment of Moderate-to-Severe Atopic Dermatitis
Psoriasis
Virtual Symposium
Managing Psoriatic Arthritis Together: A Multidisciplinary Approach to Care Between Rheumatologists and Dermatologists
Live Conference On-Demand
Deep Dive
The Gut-Skin Connection: The Microbiome and Its Effects on the Skin
LivDerm Articles
Hidradenitis Suppurativa May Involve Local Changes in the Skin
In a recent study, researchers aimed to characterize somatosensory profiles in patients with hidradenitis suppurativa (HS) at clinically affected and nonaffected areas compared with pain-free…
Arcutis Announces Positive Long-Term Results of Roflumilast Cream 0.15%
Arcutis Biotherapeutics recently announced the interim results of its phase 3, long-term extension trial of roflumilast cream 0.15% for the treatment of atopic dermatitis (AD)…
Optimizing Acne Treatment Using Ceramide-Containing Skincare
Early in 2023, a group of nine dermatologists met to review and discuss the current literature on acne to understand both the socioeconomic and psychological…
Study Evaluates Effects of Age and Sex on Alopecia Areata Comorbidities
Researchers sought to clarify the association between age and sex with various comorbidities in patients with alopecia areata.
Meet Karan Lal, DO, MS, Featured Speaker at SBS: West Coast Derm
Karan Lal, DO, MS, is a double-board-certified dermatologist who specializes in adult, pediatric, and cosmetic dermatology. His impressive educational background serves as a demonstration of…
Study Shows Supplement Containing Amino Acid May Improve Efficacy of Hair Loss Treatments
Study evaluates efficacy of oral supplement containing hydrolyzed collagen and amino acids with drug treatments in patients with hair loss.
Launch of New Hair Regrowth Serum with Exosomes
ExoCel Bio™ has announced the launch of Refine, their new Exovex™ serum with a 75 billion concentration of exosomes, designed for hair regrowth. This high…
Study Shows Dupilumab Successful in Treating Bullous Pemphigoid
A recent retrospective cohort study revealed that dupilumab was successful in treating bullous pemphigoid (BP). The study, which was conducted from Jan. 1, 2021, to…
Ava T. Shamban, MD at SBS: West Coast Derm
Ava T. Shamban, MD, is a board-certified dermatologist with over 20 years of experience in the field. A scientist, researcher, and business owner, Dr. Shamban’s…
Risankizumab Demonstrates Superior Efficacy in Treating Plaque Psoriasis as Compared to Apremilast in Phase 4 Study
In a recent study published in the British Journal of Dermatology, it was found that for patients with moderate psoriasis, treatment with risankizumab demonstrated superior…
Study Shows Combining Glycyrrhizin Tablets with 308 nm Excimer Laser Effective in Treating Vitiligo
During a recent systematic review, researchers determined that compound glycyrrhizin tablets combined with the 308 nm excimer laser proved more effective in treating vitiligo than…
Retinol-Containing Neck Cream Improves Signs of Aging
Study reveals that retinol-containing topical neck cream significantly improved signs of aging by reducing lines, wrinkles, and crepiness.
Topical Therapeutic Demonstrates Significant Improvement in Atopic Dermatitis
Alphyn Biologics recently announced results from the first cohort of its Phase 2a clinical trial of AB-101a in treating atopic dermatitis.
Almirall Reveals Data From Tildrakizumab Study Demonstrates Significant Improvement in Wellbeing for Patients with Plaque Psoriasis
Almirall's study shows tildrakizumab (Ilumetri®) significantly improved the wellbeing of patients with moderate-to-severe plaque psoriasis.
FDA Approves Verrica Pharmaceuticals Cantharidin for the Treatment of Molluscum Contagiosum
The FDA has approved cantharidin (YCANTH™) for the treatment of molluscum contagiosum in pediatric and adult patients.
ALLEGRO Trial Reports Safety and Efficacy of Ritlecitinib in Adolescent Patients with Alopecia Areata
The clinical trial of ritlecitinib reports the drug demonstrated efficacy, improvement, and an acceptable safety profile.
Incyte Announces Positive Topline Results of Phase 3 Trial of Ruxolitinib for Treating Pediatric AD
Incyte announces positive results from its trial evaluating the safety and efficacy of ruxolitinib cream in pediatric patients with AD.
New Data Reveals Spesolimab Reduces Risk of General Pustular Psoriasis Flares
Data from Boehringer Ingelheim’s Effisayil 2 reveal that spesolimab significantly reduced the risk for generalized pustular psoriasis flares.
New Data Shows Nemolizumab Rapidly Improves Itch in Adults With Prurigo Nodularis
Galderma's Olympia 2 study evaluating the safety and efficacy of nemolizumab in patients with prurigo nodularis shows positive results.
Study of Oral Orismilast Reveals Positive Results for Adult Patients with HS
UNION therapeutics has announced positive topline results from its study of oral orismilast in adult patients with hidradenitis suppurativa.
LivDerm Podcasts
Updates in JAK Inhibitor Therapies for Alopecia Areata with Brett King, MD
Nuanced Treatment of Pediatric Alopecia Areata with Brittany Craiglow, MD
Navigating the Expanding Treatment Landscape for Pediatric Patients with Atopic Dermatitis
Pearls for Early and Accurate Diagnosis of Infantile Atopic Dermatitis
Improving Communication and Shared Decision-Making with Caregivers of Patients with Atopic Dermatitis
The New Kids on the Block: IL-13 Inhibitors for the Treatment of Moderate-to-Severe Atopic Dermatitis
The New Kids on the Block: IL-13 Inhibitors for the Treatment of Moderate-to-Severe Atopic Dermatitis
Dermatologic Care in the Sexual and Gender Diverse Patient with Klint Peebles, MD
The Latest Advances in Cosmetic Dermatology with Doris J. Day, MD
The Latest Advances with Energy-Based Devices and Scar Treatments with Michael H. Gold, MD, FAAD
Anatomy Matters: The Cadaver Lab Experience with Z. Paul Lorenc, MD
Finding the Fountain of Youth: How Light Keeps Your Skin Glowing
Connect With Us
Looking for more information on our educational opportunities? Please fill out the form below to be contacted by one of our education advisors.
